Preface... iii Contents...vii Contributors...xv. 1 Introduction to Hot-Melt Extrusion, Continuous Manufacturing: Scale-up via Hot-Melt Extrusion...

Similar documents
Pharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications

Computation of Solubility parameters using Molecular. dynamics simulation

The objective of this study was to investigate solid dispersions (SDs) of poorly water soluble drug carbamazepine (CBZ),

Figure 1. Standard spray congealing setup.

Product Quality Control of a HME Co-Extrudate Using a Raman Imaging Microscope

Quantitation of amorphous content

METHOCEL. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

1/31/ Plastics Processing. Thermoplastics (Tampere)

Advances in Twin Screw Compounding Technology

Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients

Application Note. Introduction. Analysis of crystal polymorphism by Raman Spectroscopy for Medicine Development

PREPARED BY: DR. RAHIMAH OTHMAN FOOD ENGINEERING (ERT 426) SEMESTER 1 ACADEMIC SESSION 2016/17

Approaches to the formulation of poorly soluble drugs

NISSO HPC for Pharmaceutical Applications

Recent Advances in Oral Granules and Bi-Layer Tablet Technologies, Solubility Enhancement Solutions, and Oral Disintegrating Tablet Applications

POLY(LACTIC ACID) BASED SINGLE COMPOSITES

Improving Oral Bioavailability by Solid Dispersions: An OSPHENA (Ospemifene) Case Study

International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW

MiniLab-Compounder and Reactor

GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs)

TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR NEW VETERINARY DRUG SUBSTANCES AND NEW MEDICINAL PRODUCTS: CHEMICAL SUBSTANCES

On-Demand Manufacturing of Pharmaceuticals

Eudragit. Setting benchmarks in oral solid dosage forms since 1954.

Table of Contents. Robert A. Malloy. Plastic Part Design for Injection Molding. An Introduction ISBN:

Design and Dosage Form. Dr. Deny Susanti

PROCESS ECONOMICS PROGRAM

Solubility of Solid Dispersions of Pizotifen Malate and Povidone

Dow Pharma Solutions. ETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient.

Calcium Carbonate in Blown HDPE Film

NOVEL DRUG DELIVERY SYSTEMS II

EXTRUSION TECHNOLOGY. Extruders and extrusion lines

Public Assessment Report. Scientific discussion. Lacidipine Double-e Pharma 2 mg, 4 mg and 6 mg film-coated tablets. (lacidipine)

Roller Compaction: New trends, challenges and solutions

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

OSDrC OptiDose : A Revolution in Drug Formulation Technology

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

Injection Moulding and Heat Treatment of Ni-Cr-Si-B Alloy Powder

Micophotometric Control of Particles and Inhomogeneities in Flowing Polymer Melts during Extrusion Processing

DIRECTLY COMPRESSIBLE MEDICATED CHEWING GUM (MCG) FOR STAYING ALERT

Chapter TYPE OF EXTRUDERS AND EXTRUSION CONDITIONS

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products

A practical computational tool to predict formulation and process variables during the development of spray-dried amorphous solid dispersions.

Pharma Ingredients & Services. Ludiflash. Technical Information

MASTER FILE PROCEDURES

Investigating Differences in Solubility Between Crystalline and Amorphous Forms of Pharmaceuticals

Influence of different solvents on crystal property and solubility characteristics of Carbamazapine

Additive and Colour Preparations. for Extruded Polystyrene Foams

Kollidon SR: A polyvinyl acetate based excipient for DCsustained-release

PLASTICS. Characterization and Failure Analysis of.

Pharmaceutical Formulation Development of Peptides and Proteins

Laser Welding of Engineering Plastics

Stability Report. Stability profile of. BIWG 98 SE tablets 40 mg SR of 133. This stability report comprises 133 pages.

Application of Quality by Design in formulation and process Development

SOLVING ADHESION AND DIE BUILDUP PROBLEMS IN EXTRUSION COATING

BIODEGRADATION KINETICS OF BIOPOLYMERS AND BIOCOMPOSITES

D y n a m a r. The Effects of Processing Aids on the Hot-Tack Properties of LLDPE Blown Films. Polymer Processing Additives

How to Analyze Polymers Using X-ray Diffraction

ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers

zahnrad_neu_gb :46 Uhr Seite 1 Gear Pumps

Salient Features of IP-2010 (VI edition)

Extrusion. Key Issues to Address. Lecture 2. Process. Process Variants. Process Analysis. Problem Solving

How to Identify Critical Quality Attributes and Critical Process Parameters

MATERIAL SAFETY DATA SHEET

Guideline on the chemistry of active substances for veterinary medicinal products

"NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY

Mr. Amit Ray Executive Director-Packaging Division Uflex Pvt. Ltd.

Material Safety Data Sheet

Final Year Project Proposal 1

PARALOID EXL 2314 Impact Modifier

Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate

Transdermal Drug Delivery System Regulatory Requirements (USA)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE:

RHEOLOGICAL PROPERTIES ROSAND RH7 & RH10 RHEOLOGICAL INSTRUMENTS BACKED WITH RHEOLOGICAL EXPERIENCE

Effective troubleshooting of extrusion problems

Effect of Formulation and Process Variables

GUIDE TO INSPECTIONS OF STERILE DRUG SUBSTANCE MANUFACTURERS

Outline CLINICALLY RELEVANT SPECIFICATIONS. ISPE Process Validation Conference September 2017 Bethesda, MD

LEGAL REQUIREMENTS FOR STABILITY

PHARMACEUTICAL TESTING

Roller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma

Automated English Translation of Brazil RDC using Google Translate NATIONAL HEALTH SURVEILLANCE AGENCY

Modeling and simulation of drug release through polymer hydrogels. Shantanu Maheshwari, Sivakumar Cherlo, Rama Subba Thavva and Venkataramana Runkana

Colour and Additive Preparations. for Extruded Polyolefin Foams

O RAL. Tablets HANDBOOK OF PHARMACEUTICAL VOLUME I - Part ONE. Immediate Release GENERIC DEVELOPMENT

BCS Guidance and Biowaivers BCS Monographs

Legal Notice copyright 2015 Romaco Innojet GmbH

P. Pereira, C. N. Barbosa, J. C. Viana. University of Minho, Portugal

FURTHER DETAIL FROM DSC THERMOGRAMS

COMPARISON STUDY OF GRINDING AND SLURRY METHOD ON PHYSICOCHEMICAL CHARACTERISTIC OF ACYCLOVIR SUCCINIC ACID COCRYSTAL

USP Hypromellose Phthalate

dear reader: Solubilization as a solution to the challenges facing the pharma industry

CHARACTERIZATION OF THE DIRECT-SMC (D-SMC) PROCESS

Packaging technology. Fundamentals, materials and processes. Edited by. Anne Emblem and Henry Emblem WOODHEAD PUBLISHING

R&D TO PRODUCT: HOW TO REDUCE COSTLY SCALE-UP PROBLEMS

The Raman effect, discovered in 1928 by C.V. Raman in his

Chemical Foaming Alternatives to Azodicarbonamide

Preparation of Cefpodoxime Proxetil - Polymeric Microspheres by the Emulsion Solvent Diffusion Method for taste masking

Coathylene Polymer Powders

The Development of PVP-based Solid Dispersions using Hot Melt Extrusion for the Preparation of Immediate Release Formulations Chan Siok Yee

Transcription:

Contents Preface... iii Contents...vii Contributors...xv 1 Introduction to Hot-Melt Extrusion, Continuous Manufacturing: Scale-up via Hot-Melt Extrusion... 1 1 Background... 1 1.1 Introduction... 1 1.1.1 Hot-Melt Extrusion Process Technology... 2 1.1.2 Equipment... 3 1.1.3 Benefits and Drawbacks to Hot-Melt Extrusion... 4 1.1.4 Application of Hot-Melt Extrusion... 5 1.1.5 Materials used in Hot-Melt Extrusion Processes... 6 1.1.6 Development of Sustained-release Formulations... 7 1.1.7 Marketed Products... 7 1.2 Continuous Manufacturing... 8 1.3 Scale-up via Hot-Melt Process... 10 1.3.1 Case Study: Scale-up of a Hot-Melt Extrusion Process using Soluplus as Carrier... 11 1.4 Conclusions... 14 References... 15 2 Hot-Melt Extrusion as Continuous Manufacturing Technique, Current Trends and Future Perspectives... 19 2.1 Hot-Melt Extrusion as Continuous Manufacturing Technique... 19 2.1.1 Hot-Melt Extrusion Equipment... 21 2.1.2 Single-screw Extruder... 24 vii

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up 2.1.3 Twin-screw Extruders... 24 2.1.4 Role of Glass Transition Temperature... 26 2.1.5 Role of Mechanical Parameters... 26 2.1.6 Use of Plasticisers or Surfactants... 26 2.1.7 Challenges and Opportunities... 26 2.2 Background Information on Batch Processing... 27 2.2.1 Past and Future Trends of Continuous Manufacturing... 28 2.2.2 Conventional Batch Process Design... 29 2.2.3 Production Parameters... 29 2.2.4 Production Parameters in Batch Processing... 29 2.2.4.1 Active Pharmaceutical Ingredient(s) Manufacturing Site... 29 2.2.4.2 Formulation Development... 29 2.2.4.3 Industrial Scale-up... 30 2.2.4.4 Regulatory Guidelines... 30 2.2.5 Validation of Batch Processing... 30 2.2.6 In-line Continuous Monitoring Techniques... 30 2.3 Assimilation of Complete Quality-by-Design Models... 35 2.3.1 Chief Modification in Procedural Expertise for Continuous Manufacturing... 35 2.3.2 Process Parameters for Preformulation for Hot-Melt Extrusion... 36 2.3.3 Implementation of a New Product Development Process... 36 2.3.3.1 Modelling Simulation of Hot-Melt Extrusion Process... 36 2.3.4 Flow Chart Model for Continuous Hot-Melt Extrusion based Pharmaceutical Manufacturing Process... 39 2.3.5 Foremost Alteration in Structural Provisions for Quality and Technical Operations... 41 2.3.6 Potential Benefits of Continuous Hot-Melt Extrusion Manufacturing... 44 2.3.7 Regulatory Issues Related to Hot-Melt Extrusion... 44 viii

Contents 2.3.8 Process Analytical Technology Framework... 45 2.4 Conclusion... 46 References... 47 3 Co-extrusion as a Novel Approach in Continuous Manufacturing Compliance... 53 3 Background... 53 3.1 Introduction... 53 3.2 Applications of Co-extrusion via Hot-Melt Extrusion in Continuous Manufacturing... 54 3.2.1 Problem Encountered During Co-extrusion... 55 3.2.2 Variation of the Die Temperature... 55 3.2.3 Swelling of the Die... 55 3.2.4 Viscosity Matching... 56 3.2.5 Adhesion... 56 3.2.6 Interdiffusion... 56 3.2.7 Delamination... 57 3.3 Pharmaceutical Applications... 57 3.3.1 Pharmaceutical Significance of the Co-extrusion Technique... 57 3.4 Case Study... 58 3.5 Conclusions... 59 References... 59 4 Solid-state Engineering of Drugs using Melt Extrusion in Continuous Process... 63 4 Introduction... 63 4.1 Dissolution Enhancement... 63 4.1.1 Use of Novel Inorganic Excipients... 63 4.1.2 Use of Polymers to Enhance Dissolutions of Poorly Water-soluble Active Pharmaceutical Ingredients... 67 4.1.3 Continuous Co-crystallisation Engineering... 68 4.1.4 Polymorphic Transformations via Hot-Melt Extrusion... 69 ix

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up 4.1.4.1 Polymorphic Transformation of Carbamazepine... 70 4.1.4.2 Polymorphic Transformation of Artemisinin... 70 References... 71 5 Continuous Co-crystallisation of Poorly Soluble Active Pharmaceutical Ingredients to Enhance Dissolution... 75 5.1 Introduction... 75 5.2 Mechanism of Continuous Co-crystallisation by Twin-screw Extrusion... 79 5.2.1 Eutectic-mediated Co-crystallisation... 80 5.2.1.1 Ibuprofen-Nicotinamide Case... 80 5.2.1.2 Carbamazepine-Saccharin Case... 81 5.2.2 Solvent-assisted Co-crystallisation... 85 5.2.3 Amorphous Phase-mediated Co-crystallisation... 87 5.2.3.1 AMG 517-Sorbic Acid Case... 87 5.3 Critical Parameters Influencing Continuous Co-crystallisation by Twin-screw Extrusion... 89 5.3.1 Processing Temperature... 89 5.3.2 Temperature-dependent Case... 89 5.3.3 Temperature-independent Case... 89 5.3.4 Screw Design... 90 5.3.5 Screw Speed... 90 5.3.6 Feed-rate... 91 5.4 Case Study... 91 5.4.1 Matrix-assisted Co-crystallisation of Carbamazepine-Nicotinamide System by Twin-screw Extrusion... 91 5.4.2 Avoiding Thermal Degradation of Carbamazepine through In Situ Co-crystallising with Nicotinamide... 92 5.5 Conclusions... 93 References... 93 x

Contents 6 Taste Masking of Bitter Active Pharmaceutical Ingredients for the Development of Paediatric Medicines via Continuous Hot-Melt Extrusion Processing... 97 6 Introduction... 97 6.1 Hot-Melt Extrusion as an Active Taste Masking Technique... 97 6.1.1 Taste Masking via Continuous Hot-Melt Extrusion Process... 97 6.1.2 Polymers as Suitable Carriers for Taste Masking... 99 6.1.3 Use of Lipids as Carriers for Taste Masking in Hot-Melt Extrusion... 104 6.2 Continuous Manufacturing of Oral Films via Hot-Melt Extrusion... 105 6.2.1 Case Study: Taste Masking of Bitter Active Pharmaceutical Ingredients via Continuous Hot-Melt Extrusion Processing... 106 6.3 Materials... 107 6.3.1 In Vivo Taste Masking Evaluation... 107 6.3.2 In Vitro Taste Masking Evaluation: Astree e-tongue... 107 6.3.3 Sample Preparation for Astree e-tongue... 108 6.4 Results and Discussion... 108 6.4.1 In Vivo/In Vitro Taste Evaluations... 111 6.5 Conclusions... 115 References... 115 7 Continuous Manufacturing of Pharmaceutical Products via Melt Extrusion: A Case Study... 121 7 Introduction... 121 Case Study... 122 7.1 Materials and Method... 122 7.1.1 Materials... 122 7.1.2 Preparation of Formulation Blends and Continuous Hot-Melt Extrusion Processing... 122 7.1.3 Scanning Electron Microscopy/Energy Dispersive X-ray Analysis... 123 xi

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up 7.1.4 Thermal Analysis... 123 7.1.5 Powder X-ray Diffraction... 124 7.1.6 In Vitro Drug Release Studies... 124 7.1.7 Analysis of Drug Release Mechanism... 124 7.2 Results and Discussion... 126 7.2.1 Continuous Manufacturing of Pellets via Hot-Melt Extrusion... 127 7.2.2 Advanced Surface Analysis... 129 7.2.4 Thermal Analysis... 130 7.2.5 Amorphicity Analysis... 131 7.2.6 In Vitro Dissolution Studies... 132 7.2.7 Analysis of Release Mechanism... 133 7.3 Conclusions... 135 References... 136 8 Novel Pharmaceutical Formulations Using Hot-Melt Extrusion Processing as a Continuous Manufacturing Technique... 139 8 Introduction... 139 8.1 Materials and Methods... 140 8.1.1 Materials... 140 8.1.2 Hot-Melt Extrusion Processing... 140 8.1.3 Differential Scanning Calorimetry Analysis... 140 8.1.4 Hot Stage Microscopy Analysis... 140 8.1.5 X-ray Powder Diffraction... 141 8.1.6 In Vitro Drug Release Studies... 141 8.1.7 High-performance Liquid Chromatography Analysis... 141 8.2 Results and Discussion... 142 8.2.1 Hot-Melt Extrusion Processing... 142 8.2.2 Thermal Analysis... 142 8.2.3 X-ray Powder Diffraction Analysis... 144 8.2.4 In Vitro Dissolution Studies... 145 8.3 Conclusions... 146 References... 147 xii

Contents 9 Continuous Polymorphic Transformations Study via Hot-Melt Extrusion Process... 149 9 Background... 149 9.1 Polymorphism... 149 9.2 Case Study: Polymorphic Transformation of Paracetamol... 150 9.2.1 Experimental Methods... 151 9.2.2 Theoretical Calculation... 151 9.2.3 Continuous Hot-Melt Extrusion Process and In-line Monitoring... 152 9.2.4 Thermal Analysis... 153 9.3 Results and Discussion... 154 9.3.1 Continuous Extrusion Process and Theoretical Consideration... 154 9.3.2 Physicochemical Characterisation of the Polymorphic Transformation during Hot-Melt Extrusion... 156 9.3.3 In-line Near-infrared Spectroscopy Monitoring... 163 9.4 Conclusions... 165 References... 165 10 From Pharma Adapted Extrusion Technology to Brand New Pharma Fitted Extrusion Design: The Concept of Micro-scale Vertical Extrusion and its Impact in Terms of Scale-up Potential... 169 10 Introduction... 169 10.1 The Advantages of Hot-Melt Extrusion... 170 10.1.1 Examples of Problems Solved Thanks to Hot-Melt Extrusion... 170 10.2 From Micro-scale to Industrial-scale... 171 10.2.1 Viscosity of the Three Samples at Different Temperatures... 172 10.2.2 Viscosity at Various Temperatures... 173 10.3 Hot-Melt Extrusion as a Standard Technology for the Pharmaceutical Industry... 174 10.4 Innovations... 175 xiii

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up 10.5 Conclusions... 179 References... 179 11 Continuous Manufacturing via Hot-Melt Extrusion and Scale-up: Regulatory Aspects... 181 11 Introduction... 181 11.1 Continuous Manufacturing and Hot-Melt Extrusion Processing Technology... 181 11.2 Aspects of the Controls/Parameters in Hot-Melt Extrusion Processing... 184 11.3 Continuous Manufacturing via Hot-Melt Extrusion... 185 11.4 Continuous Manufacturing Process over Batch Process... 187 11.5 Scale-up Methodologies... 188 11.6 Regulatory Aspects... 191 11.7 Summary... 193 References... 193 Abbreviations... 197 Index... 201 xiv